Prophylactic Antibiotic Regimens in Tumour Surgery (PARITY): A Multi-Centre International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumour Resections With Endoprosthetic Replacements
The Prophylactic Antibiotic Regimens in Tumour Surgery (PARITY) trial is the first ever
international multi-centre randomized controlled trial in bone cancer surgery. In order to
avoid amputation for bone cancer in the leg, complex limb-saving operations are performed.
However, infections with devastating complications following surgery are common. Surgeons
from across the world will randomize patients to receive either short- or long-duration
antibiotic regimens after surgery with the goal of identifying the best regimen to reduce
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society